Skip to main content

Advertisement

Log in

Pulsed reduced dose-rate radiotherapy: case report

A novel re-treatment strategy in the management of recurrent glioblastoma multiforme

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The initial management of malignant gliomas is multimodality in nature, consisting of surgery, radiation therapy and chemotherapy. However, once progression has occurred, treatment options are limited both in terms of selection and efficacy. We report a case of a 37 year-old male diagnosed with a Grade II astrocytoma initially treated with surgery and external beam radiation therapy consisting of 54 Gy delivered in 1.8 Gy fractions that subsequently progressed to a Grade IV astrocytoma. This was managed with temozolomide chemotherapy until the patient exhibited further progression. Although the patient had received prior full dose radiotherapy, he was re-treated with external beam radiotherapy delivered at a substantially reduced dose-rate. This reduction in dose-rate is obtained by delivering treatment in a series of 0.2 Gy pulses separated by 3 min time intervals, creating an apparent dose rate of 0.0667 Gy/min. The region of recurrence was treated to a dose of 50 Gy delivered using 25 daily fractions of 2.0 Gy. The patient had both a radiographic response and clinical improvement following re-irradiation using pulsed reduced dose-rate radiotherapy with no apparent acute or late neurologic toxicities at a time when other treatment options were not available. Despite delivering 104 Gy to the tumor bed and the surrounding brain parenchyma, at no time was there radiographic evidence of radiation-induced normal tissue necrosis. The radiobiologic basis for the use of pulsed reduced dose-rate external beam radiotherapy in the management of recurrent glioma patients is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ammirati M, et al (1987) Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21(2):201–206

    Article  PubMed  CAS  Google Scholar 

  2. Walker MD, et al (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303(23):1323–1329

    Article  PubMed  CAS  Google Scholar 

  3. Walker MD, et al (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49(3):333–343

    Article  PubMed  CAS  Google Scholar 

  4. Stupp R, et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

    Article  PubMed  CAS  Google Scholar 

  5. Hess KR, et al (1999) Response and progression in recurrent malignant glioma. Neuro-oncol 1(4):282–288

    Article  PubMed  CAS  Google Scholar 

  6. Chang SM, et al (2004) Temozolomide in the treatment of recurrent malignant glioma. Cancer 100(3):605–611

    Article  PubMed  CAS  Google Scholar 

  7. Tatter SB (2002) Recurrent malignant glioma in adults. Curr Treat Options Oncol 3(6):509–524

    PubMed  Google Scholar 

  8. Durmaz R, et al (1997) Management of glioblastoma multiforme: with special reference to recurrence. Clin Neurol Neurosurg 99(2):117–123

    Article  PubMed  CAS  Google Scholar 

  9. Salcman M, et al (1994) Long-term survival in patients with malignant astrocytoma. Neurosurgery 34(2):213–219 discussion 219–220

    Article  PubMed  CAS  Google Scholar 

  10. Tomé WA, Howard SP (2006) On the possible increase in local tumor control probability for gliomas exhibiting low dose hyper-radiosensitivity using a pulsed schedule. Br J Radiology Advance 10.1259/bjr/15764945

  11. Bauman GS, et al (1996) Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 36(2):433–441

    Article  PubMed  CAS  Google Scholar 

  12. Veninga T, et al (2001) Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol 59(2):127–137

    Article  PubMed  CAS  Google Scholar 

  13. Butowski NA, Sneed PK, Chang SM (2006) Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol 24(8):1273–1280

    Article  PubMed  CAS  Google Scholar 

  14. Schultz CJ, Geard CR (1990) Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. Int J Radiat Oncol Biol Phys 19:1397–1403

    PubMed  CAS  Google Scholar 

  15. Schultz CJ, Davies BM (1994) G2M block characteristics as a function of dose rate in two human glioblastoma cell lines. In: Proceedings of the Radiation Research Society 42nd Annual Meeting, Nashville, TN

  16. Pierquin B, et al (1991) Comparison of fractionated irradiation and low-dose rate irradiation in the local treatment of advanced breast cancer. Bulletin Du Cancer/Radiotherapie 78: 125–132

    Google Scholar 

  17. Pierquin B, et al (1985) A comparison between low dose rate radiotherapy and conventionally fractionated irradiation in moderately extensive cancers of the oropharynx. Int J Radiat Oncol Biol Phys 11(3):431–439

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven P. Howard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cannon, G.M., Tomé, W.A., Robins, H.I. et al. Pulsed reduced dose-rate radiotherapy: case report. J Neurooncol 83, 307–311 (2007). https://doi.org/10.1007/s11060-007-9329-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-007-9329-z

Keywords

Navigation